AGP Executive Report
Last update: 3 hours agoGLP-1 Legal Clash: Novo Nordisk filed a federal lawsuit in New Jersey against Eli Lilly, accusing Lilly of “deceptive” nationwide ads that compare Zepbound/Mounjaro highest doses to older, lower-dose versions of Wegovy/Ozempic—Novo says the claims use outdated trial data and omit newer context. Food Safety Alert: A cyclosporiasis-linked iceberg lettuce recall continues to affect shoppers in New Jersey and 26 other states, but FDA says some lab results were a false positive—health experts stress you should avoid only the specific recalled products and check packaging. Drug Recall: A New Jersey-based company, Rising Pharma Holdings, issued a voluntary recall of certain 5 mg cetirizine tablets after possible cross-contamination with ranitidine, which could trigger life-threatening allergic reactions. Health Coverage Proposal: Sen. Andy Kim (D-NJ) unveiled the MediKids Act, a long-shot plan to automatically enroll every child in federally funded coverage from birth through age 26. Behavioral Health Expansion: Beacon Behavioral Partners expanded into Michigan and Ohio through a deal with Pure Psychiatry, adding 17 outpatient locations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.